NHS North West Genomics
2.0.12 - ci-build United Kingdom flag

NHS North West Genomics - Local Development build (v2.0.12) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions

: North West Genomics Test Code - XML Representation

Active as of 2026-06-04

Raw xml | Download


<CodeSystem xmlns="http://hl7.org/fhir">
  <id value="NWTestCode"/>
  <text>
    <status value="generated"/>
    <div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: CodeSystem NWTestCode</b></p><a name="NWTestCode"> </a><a name="hcNWTestCode"> </a><p>This case-sensitive code system <code>https://fhir.nwgenomics.nhs.uk/CodeSystem/NWTestCode</code> defines the following codes:</p><table class="codes"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td></tr><tr><td style="white-space:nowrap">HX01<a name="NWTestCode-HX01"> </a></td><td>Genomic testing (Haemato-Oncology) Not in National Genomic Test Directory</td></tr><tr><td style="white-space:nowrap">MX01.1<a name="NWTestCode-MX01.461"> </a></td><td>Genomic testing (Solid Tumour), Not in National Genomic Test Directory</td></tr><tr><td style="white-space:nowrap">MX02.1<a name="NWTestCode-MX02.461"> </a></td><td>BRAF V600E Testing, Lynch syndrome</td></tr><tr><td style="white-space:nowrap">MX04.1<a name="NWTestCode-MX04.461"> </a></td><td>DNA to be stored, Cancer (Other)</td></tr><tr><td style="white-space:nowrap">MX05.1<a name="NWTestCode-MX05.461"> </a></td><td>RNA to be stored, Cancer (Other)</td></tr><tr><td style="white-space:nowrap">MX07.1<a name="NWTestCode-MX07.461"> </a></td><td>FaR-RMS trial, Multi-target NGS Panel, small variant</td></tr><tr><td style="white-space:nowrap">MX07.2<a name="NWTestCode-MX07.462"> </a></td><td>FaR-RMS trial, Multi-target NGS panel, structural variant</td></tr><tr><td style="white-space:nowrap">MX08.1<a name="NWTestCode-MX08.461"> </a></td><td>Melanoma, Detection trial, small variant (BRAF, NRAS, TERT)</td></tr><tr><td style="white-space:nowrap">MX10.1<a name="NWTestCode-MX10.461"> </a></td><td>Triple-Negative Myeloproliferative Neoplasm (MPN), MPL non-canonical variant screening</td></tr><tr><td style="white-space:nowrap">MX11.1<a name="NWTestCode-MX11.461"> </a></td><td>Acute Myeloid Leukaemia (AML), FLT3-ITD MRD</td></tr><tr><td style="white-space:nowrap">MX12.1<a name="NWTestCode-MX12.461"> </a></td><td>Large-Cell Neuroendocrine Carcinoma (LCNEC) Project</td></tr><tr><td style="white-space:nowrap">MX13.1<a name="NWTestCode-MX13.461"> </a></td><td>Colorectal Cancer, Multi-target ctDNA NGS panel, small variant</td></tr><tr><td style="white-space:nowrap">MX14.1<a name="NWTestCode-MX14.461"> </a></td><td>Cancer of Unknown Primary, Multi-target ctDNA NGS panel, small variant</td></tr><tr><td style="white-space:nowrap">RX01.1<a name="NWTestCode-RX01.461"> </a></td><td>Genomic testing (Rare Disease) Not in National Genomic Test Directory</td></tr><tr><td style="white-space:nowrap">RX02.1<a name="NWTestCode-RX02.461"> </a></td><td>Genomic testing Research Study</td></tr><tr><td style="white-space:nowrap">RX03.1<a name="NWTestCode-RX03.461"> </a></td><td>Complement Tx i-Gain Clinical Trial</td></tr><tr><td style="white-space:nowrap">RX03.2<a name="NWTestCode-RX03.462"> </a></td><td>Genomic testing Clinical Trial</td></tr><tr><td style="white-space:nowrap">RX04.1<a name="NWTestCode-RX04.461"> </a></td><td>Molecular Pathology of Human Genetic Disease (HumGenDis)</td></tr><tr><td style="white-space:nowrap">RX05.1<a name="NWTestCode-RX05.461"> </a></td><td>LEAP Study</td></tr><tr><td style="white-space:nowrap">RX06.1<a name="NWTestCode-RX06.461"> </a></td><td>Implementing Pharmocogenetics to Improve Prescribing (IPTIP)</td></tr><tr><td style="white-space:nowrap">RX07.1<a name="NWTestCode-RX07.461"> </a></td><td>TPMT (Thiopurine S-methyltransferase) genotyping (Targeted variant testing)</td></tr><tr><td style="white-space:nowrap">RX08.1<a name="NWTestCode-RX08.461"> </a></td><td>Factor V Leiden and Prothrombin thrombophilia (FVL and PGV)</td></tr><tr><td style="white-space:nowrap">RX09.1<a name="NWTestCode-RX09.461"> </a></td><td>Genome-wide DNA Methylation Profiling (Methylation testing)</td></tr><tr><td style="white-space:nowrap">RX11.1<a name="NWTestCode-RX11.461"> </a></td><td>Jewish BRCA Project Germline Screening</td></tr><tr><td style="white-space:nowrap">RX16.1<a name="NWTestCode-RX16.461"> </a></td><td>FOVEA Study</td></tr><tr><td style="white-space:nowrap">RX18.1<a name="NWTestCode-RX18.461"> </a></td><td>Inherited ovarian cancer (without breast cancer) RetroBRCA Project</td></tr><tr><td style="white-space:nowrap">RX18.2<a name="NWTestCode-RX18.462"> </a></td><td>Inherited breast cancer and ovarian cancer RetroBRCA Project</td></tr><tr><td style="white-space:nowrap">RX19.1<a name="NWTestCode-RX19.461"> </a></td><td>PROGRESS Study</td></tr><tr><td style="white-space:nowrap">RX20.1<a name="NWTestCode-RX20.461"> </a></td><td>Renal Tract Abnormalities Study</td></tr><tr><td style="white-space:nowrap">RX21.1<a name="NWTestCode-RX21.461"> </a></td><td>Ashkenazi Jewish and Polish Population Screening (Targeted variant testing)</td></tr><tr><td style="white-space:nowrap">XX01.1<a name="NWTestCode-XX01.461"> </a></td><td>Not Processed (No Extraction)</td></tr><tr><td style="white-space:nowrap">XX02.1<a name="NWTestCode-XX02.461"> </a></td><td>Cell line extraction &amp; aliquot for DNA storage (Other)</td></tr></table></div>
  </text>
  <url value="https://fhir.nwgenomics.nhs.uk/CodeSystem/NWTestCode"/>
  <version value="2.0.12"/>
  <name value="NWTestCode"/>
  <title value="North West Genomics Test Code"/>
  <status value="active"/>
  <experimental value="false"/>
  <date value="2026-06-04"/>
  <publisher value="NHS North West Genomics"/>
  <contact>
    <telecom>
      <system value="url"/>
      <value value="https://www.nwgenomics.nhs.uk/contact-us"/>
    </telecom>
  </contact>
  <description value="HL7 v2 CodeSystem : NWTestCode"/>
  <jurisdiction>
    <coding>
      <system value="urn:iso:std:iso:3166"/>
      <code value="GB"/>
      <display value="United Kingdom of Great Britain and Northern Ireland"/>
    </coding>
  </jurisdiction>
  <caseSensitive value="true"/>
  <content value="complete"/>
  <count value="32"/>
  <concept>
    <code value="HX01"/>
    <display
             value="Genomic testing (Haemato-Oncology) Not in National Genomic Test Directory"/>
  </concept>
  <concept>
    <code value="MX01.1"/>
    <display
             value="Genomic testing (Solid Tumour), Not in National Genomic Test Directory"/>
  </concept>
  <concept>
    <code value="MX02.1"/>
    <display value="BRAF V600E Testing, Lynch syndrome"/>
  </concept>
  <concept>
    <code value="MX04.1"/>
    <display value="DNA to be stored, Cancer (Other)"/>
  </concept>
  <concept>
    <code value="MX05.1"/>
    <display value="RNA to be stored, Cancer (Other)"/>
  </concept>
  <concept>
    <code value="MX07.1"/>
    <display value="FaR-RMS trial, Multi-target NGS Panel, small variant"/>
  </concept>
  <concept>
    <code value="MX07.2"/>
    <display
             value="FaR-RMS trial, Multi-target NGS panel, structural variant"/>
  </concept>
  <concept>
    <code value="MX08.1"/>
    <display
             value="Melanoma, Detection trial, small variant (BRAF, NRAS, TERT)"/>
  </concept>
  <concept>
    <code value="MX10.1"/>
    <display
             value="Triple-Negative Myeloproliferative Neoplasm (MPN), MPL non-canonical variant screening"/>
  </concept>
  <concept>
    <code value="MX11.1"/>
    <display value="Acute Myeloid Leukaemia (AML), FLT3-ITD MRD"/>
  </concept>
  <concept>
    <code value="MX12.1"/>
    <display value="Large-Cell Neuroendocrine Carcinoma (LCNEC) Project"/>
  </concept>
  <concept>
    <code value="MX13.1"/>
    <display
             value="Colorectal Cancer, Multi-target ctDNA NGS panel, small variant"/>
  </concept>
  <concept>
    <code value="MX14.1"/>
    <display
             value="Cancer of Unknown Primary, Multi-target ctDNA NGS panel, small variant"/>
  </concept>
  <concept>
    <code value="RX01.1"/>
    <display
             value="Genomic testing (Rare Disease) Not in National Genomic Test Directory"/>
  </concept>
  <concept>
    <code value="RX02.1"/>
    <display value="Genomic testing Research Study"/>
  </concept>
  <concept>
    <code value="RX03.1"/>
    <display value="Complement Tx i-Gain Clinical Trial"/>
  </concept>
  <concept>
    <code value="RX03.2"/>
    <display value="Genomic testing Clinical Trial"/>
  </concept>
  <concept>
    <code value="RX04.1"/>
    <display
             value="Molecular Pathology of Human Genetic Disease (HumGenDis)"/>
  </concept>
  <concept>
    <code value="RX05.1"/>
    <display value="LEAP Study"/>
  </concept>
  <concept>
    <code value="RX06.1"/>
    <display
             value="Implementing Pharmocogenetics to Improve Prescribing (IPTIP)"/>
  </concept>
  <concept>
    <code value="RX07.1"/>
    <display
             value="TPMT (Thiopurine S-methyltransferase) genotyping (Targeted variant testing)"/>
  </concept>
  <concept>
    <code value="RX08.1"/>
    <display
             value="Factor V Leiden and Prothrombin thrombophilia (FVL and PGV)"/>
  </concept>
  <concept>
    <code value="RX09.1"/>
    <display
             value="Genome-wide DNA Methylation Profiling (Methylation testing)"/>
  </concept>
  <concept>
    <code value="RX11.1"/>
    <display value="Jewish BRCA Project Germline Screening"/>
  </concept>
  <concept>
    <code value="RX16.1"/>
    <display value="FOVEA Study"/>
  </concept>
  <concept>
    <code value="RX18.1"/>
    <display
             value="Inherited ovarian cancer (without breast cancer) RetroBRCA Project"/>
  </concept>
  <concept>
    <code value="RX18.2"/>
    <display
             value="Inherited breast cancer and ovarian cancer RetroBRCA Project"/>
  </concept>
  <concept>
    <code value="RX19.1"/>
    <display value="PROGRESS Study"/>
  </concept>
  <concept>
    <code value="RX20.1"/>
    <display value="Renal Tract Abnormalities Study"/>
  </concept>
  <concept>
    <code value="RX21.1"/>
    <display
             value="Ashkenazi Jewish and Polish Population Screening (Targeted variant testing)"/>
  </concept>
  <concept>
    <code value="XX01.1"/>
    <display value="Not Processed (No Extraction)"/>
  </concept>
  <concept>
    <code value="XX02.1"/>
    <display
             value="Cell line extraction &amp; aliquot for DNA storage (Other)"/>
  </concept>
</CodeSystem>